2013
DOI: 10.1007/s00381-013-2256-8
|View full text |Cite
|
Sign up to set email alerts
|

Childhood central nervous system tumors at MAHAK’s Pediatric Cancer Treatment and Research Center (MPCTRC), Tehran, Iran

Abstract: In contrast of high rate of death in this study, other general characteristics can serve as benchmark for improving our care for children with brain tumors in Iran.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

2
13
1

Year Published

2014
2014
2020
2020

Publication Types

Select...
6

Relationship

3
3

Authors

Journals

citations
Cited by 15 publications
(16 citation statements)
references
References 14 publications
2
13
1
Order By: Relevance
“…Two articles were written in Persian [8, 12], whereas the remaining 33 were written in English. Most studies (n = 27) took place in Tehran province [4–5, 8, 1113, 15–23, 25–29, 3137] in hospitals and centers affiliated with the three main medical universities in Tehran: Tehran University of Medical Sciences (n = 16) [4–5, 11, 13, 1617, 1922, 26, 2829, 3132, 37], Shahid Beheshti University of Medical Sciences (n = 6) [12, 15, 18, 25, 27, 34,], Iran University of Medical Sciences (n = 4) [8, 23, 35, 36], and Army University of Medical Science (n = 1) [33]. Only four articles [18, 23, 26, 34] stated that approval by an ethics committee had been obtained.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…Two articles were written in Persian [8, 12], whereas the remaining 33 were written in English. Most studies (n = 27) took place in Tehran province [4–5, 8, 1113, 15–23, 25–29, 3137] in hospitals and centers affiliated with the three main medical universities in Tehran: Tehran University of Medical Sciences (n = 16) [4–5, 11, 13, 1617, 1922, 26, 2829, 3132, 37], Shahid Beheshti University of Medical Sciences (n = 6) [12, 15, 18, 25, 27, 34,], Iran University of Medical Sciences (n = 4) [8, 23, 35, 36], and Army University of Medical Science (n = 1) [33]. Only four articles [18, 23, 26, 34] stated that approval by an ethics committee had been obtained.…”
Section: Resultsmentioning
confidence: 99%
“…The study objectives were categorized as clinical (n = 18 articles, 173 patients), epidemiologic (n = 9 articles [5, 8, 12–13, 16, 26, 28, 33–34], 1,881 patients), pathologic (n = 4 articles [11, 14, 15, 18], 1,160 patients), genetic (n = 2 articles [7, 30], 75 patients), surgical (n = 1 article [21], 172 patients), or radiologic (n = 1 article [29], 23 patients). Study designs were primarily single case reports (n = 16 articles [2–4, 9, 1617, 1922, 24, 29, 3132, 3637], 19 patients) and cross-sectional studies (n = 15 articles [7–8, 10–14, 15, 18, 25–26, 28, 30, 33–34], 3,271 patients).…”
Section: Resultsmentioning
confidence: 99%
See 1 more Smart Citation
“…For example, one of the most distinguished and successful pain departments is at MAHAK hospital, which focuses on pediatric cancer pain. Many different types of cancer have been reported in children admitted to MAHAK’S Pediatric Cancer Treatment and Research Center (MPCTRC) including acute lymphocytic leukemia (ALL), acute myelocytic leukemia (AML) [25], central nervous system tumors such as primitive neuroectodermal tumor (PNET) [26], and soft and hard tissue tumors [27]. …”
Section: Discussionmentioning
confidence: 99%
“…Other interventional pain management techniques accessible at this center include the use of radiofrequency and microwave for modulation, ablation, and coagulation of pain pathways, implantable analgesic pumps in the epidural or intrathecal space, along with botulinum toxin injection therapy (for headaches, muscle pains, and spasms), photodynamic therapy, aromatherapy, and music therapy [28]. There are many disease-based projects undertaken at this center [2528]. There are also a number of ongoing projects investigating the follow-up of cancer patients since 2014, which are due to be completed by 2020.…”
Section: Discussionmentioning
confidence: 99%